x Health Men's Health Children's Health Nutrition and Wellness Reproductive Health Health & Science Digital News Videos Opinions Cartoons Education E-Paper Lifestyle & Entertainment Nairobian Entertainment Eve Woman Travelog TV Stations KTN Home KTN News BTV KTN Farmers TV Radio Stations Radio Maisha Spice FM Vybez Radio Enterprise BULK SMS E-Learning Digger Classified The Standard Group Corporate Contact Us Rate Card Vacancies DCX O.M Portal Corporate Email RMS
Login ×
BTV
VAS
DCX
RMS

Children go digital in crucial malaria drug trials

Health & Science - By Gatonye Gathura | November 22nd 2020 at 12:00:00 GMT +0300
Health Chief Administrative Secretary (CAS) Rashid Aman [Wiberforce Okwiri, Standard]

Researchers have moved to cushion thousands of children in ongoing malaria drug trials from Covid-19 infections.

The pandemic hit when nearly 128,000 children in western Kenya were enrolled to take the world’s first malaria vaccine. “It is important we keep the trials going, but also crucial that everybody is safe,” said Kenya Medical Research Institute chief research officer Bernhards Ogutu.

The studies include piloting of a malaria vaccine, the first new malaria treatment for babies under five kilogrammes, a new fast-acting medicine for treatment of severe malaria, and new combinations to treat drug-resistant and uncomplicated malaria.

By the beginning of this month one million doses of the vaccine had been administered in Kenya, Ghana and Malawi with about 400,000 children having received the first of four doses.

“Despite the Covid-19 challenges, families have continued to take their children for the vaccine,” said Siaya health director Ken Oruenjo.

Covid 19 Time Series

 

Dr Oruenjo said the participants’ details are logged into an electronic register that allows researchers to remotely monitor every individual’s progress while keeping in touch with caregivers.

“We are working closely with local health authorities to anticipate and mitigate potential risks to the vaccine pilots, including those arising from the Covid-19 pandemic,” said Mary Hamel of the World Health Organisation.

The WHO predicts that due to the coronavirus emergency, deaths from malaria in sub-Saharan Africa could almost double from about 400,000 in 2018 to 770,000 this year.

In August, Health Chief Administrative Secretary Dr Rashid Aman said the number of weekly hospital visits due to malaria had dropped from about 300,000 to 100,000 since the Covid-19 outbreak in March.

The threat of all-time high malaria deaths this year is heightened by an abnormal rise in water levels and flooding around lakes Victoria, Naivasha, Baringo, Turkana, Nakuru and Bogoria.

The 2020 Economic Survey shows that malaria cases increased by 18.6 per cent to 4.7 million last year, with the Lake Victoria region accounting for the largest number of cases at 74.4 per cent.

Experts also pushed for the restart of malaria studies during a special session of the American Society of Tropical Medicine and Hygiene’s annual conference last week. “We risk losing investment in malaria research worth more than Sh63 billion and an incalculable number of lives unless the activities are restarted now,” said RBM Partnership to End Malaria CEO Abdourahmane Diallo.

Novartis head of malaria programme Caroline Boulton said, “Covid took us all by surprise at a time we were trying to initiate four different malaria clinical studies.”

Dr Boulton told the conference that some of the study sites had been turned into Covid-19 isolation and treatment centres, forcing them to innovate.

To reduce person-to-person interactions, and the risk of corona infections, she said they had to shift most activities to digital platforms.

“We can see real benefits throughout the projects including more engagement, reduced site visits, and ease in dealing with logistics challenges.


Research Covid-19 Malaria

Top Stories

Covid-19: 138 test positive as three others die
Health & Science - By Mercy Asamba


How alcoholism trickles down generations
Health & Science - By Nancy Nzalambi


Do you need to deworm? These are the signs to look out for
Health & Science - By Jael Mboga


KUCO: The strike is still on
Health & Science - By Judah Ben-Hur


Is vitiligo curable?
Health & Science - By Graham Kajilwa


Does beer make you fat?
Health & Science - By By Bob Otieno


KNH yet to lower cost of testing for virus to Sh1,000
Health & Science - By Anyango Otieno


Latest Stories

Woman's cry for justice after losing uterus in wrong surgery
Health & Science - By Mactilda Mbenywe


Covid-19: Kenya records 166 new cases, three deaths
Health & Science - By Vincent Kejitan


KUCO: The strike is still on
Health & Science - By Judah Ben-Hur


Covid-19: 138 test positive as three others die
Health & Science - By Mercy Asamba


Covid-19: 123 positives, 412 recoveries
Health & Science - By Betty Njeru


Nurses vow to continue strike until MoU signed
Health & Science - By Judah Ben-Hur


Covid-19: Positive cases under the 100-mark three days in a row
Health & Science - By Judah Ben-Hur


Pfizer appoints Patrick van der Loo as Regional President for Africa and the Middle East
Health & Science - By Standard Reporter


Medics stay put as county decries lack of cash
Health & Science - By Benard Sanga


When swallowing or passing stool needs painkillers
Health & Science - By Yvonne Kawira


//

Stay Ahead!

Access premium content only available
to our subscribers.

Or Login With Your Standard Account
Support independent journalism
×
Create An Account
Support independent journalism
I have an account Log in
Reset Password
Support independent journalism
Log in